Altogether, the above-mentioned findings indicated that miR-135a-5p over-expression targeted TXNIP to suppress NLRP3-mediated inflammation and fibrosis of CFs. Here, TXNIP is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.